18 January 2018 |

Sucrosomial Iron quoted in International Journal of Hematology

After being cited at the end of October in the eminent periodical Expert Opinion on Pharmacotherapy as an alternative in the treatment of Chronic Inflammatory Bowel Diseases, Sucrosomial Iron® – an Alesco technology patented that is the basis of our SiderAL® products – was subject of another important citation.


In an article about the Modern Martial Therapies, published in the International Journal of Hematology and written by Prof. Domenico Girelli, Professor of Internal Medicine at the University of Verona, together with his collaborators, we find almost a deepening dedicated to sucrosomial technology in reference to the new oral iron solutions today available on the market.


This is a notable recognition for PharmaNutra SPA and our Sucrosomiale Iron® – literally defined as “one of the most innovative products” in the sector – that follows the success achieved at the 59th edition of the ASH (American Society of Hematology) held from December 9th to 12th in Atlanta, in the United States. This event saw the participation of more than 20,000 professionals from all over the world. In few words, it seems increasingly clear how, thanks to its unique properties, Sucrosomiale Iron is becoming more and more the first choice in the treatment in cases of Chronic Inflammatory Bowel Diseases, such as Crohn’s disease or Ulcerative Colitis.